Antibodies to Saccharomyces cerevisiae: Are they useful in clinical practice?

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 718-720

  Candelli, M ^a   Papa, A ^a   Nista, E C ^a   Danese, S ^a   Armuzzi, A ^a   Bartolozzi, F ^a   Tondi, P ^a   Ojetti, V ^a   Gasbarrini, G ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

ASCA; Crohn's disease; Diagnosis and small bowel involvement

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, FUNGAL; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ITALY; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 0037902124     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Koutroubakis I, Petinaki E, Mouzas IA, Vlachonikolis G, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis E: Anti-Saccharomyces cerevisiae mannan antibodies and neutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96:449-454.
2. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D: Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophii cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42:788-791.
3. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P: Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96:730-734.
4. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J: Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000; 46:58-63.
5. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG: Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001; 96:758-765.
6. Vermeire S, Peeters M, Rutgeerts P: Diagnostic approach to IBD. Hepatogastroenterology 2000; 47:44-48.
7. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH: Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000; 95:359-367.
8. Targan SR: The utility of ANCA and ASCA in inflammatory bowel disease. Inflamm Bowel Dis 1999; 5:61-63.
9. Giaffer MH, Clark A, Holdsworth CD: Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 33:1071-105.
10. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parratt D: Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988; 297:1105-1106.
11. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietnic R, Rutgeerts P: Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assay in inflammatory bowel disease. Gastroenterology 2001; 120:837-833.
12. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR: Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47:487-496.
13. Cesaro S, Chinello P, Rossi L, Zanesco L: Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000; 8:504-505.
14. Perapoch J, Planes AM, Querol A, Lopez V, Martinez-Bendayan I, Tormo R, Fernandez F, peguero G, Salcedo S: Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultralevura. Eur J Clin Microbiol Infect Dis 2000; 19:468-470.
15. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P: Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7:8-15.